Bilirubin
[Bilirubin ]
EPTIS factsheet 142480 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts142480 https://www.eptis.bam.de/pts142480
| PT provider | ||||||||||
| PT provider | Weqas Weqas | |||||||||
| Based in | United Kingdom | |||||||||
| Language(s) | ||||||||||
| Remarks | In adults, Total Bilirubin is typically measured for the investigation of jaundice as part of a panel of ‘liver function’ tests. Conjugated hyperbilirubinemia is indicative of hepatobiliary dysfunction and bilirubin is often used to monitor the course of the disease. An elevated serum unconjugated bilirubin is characteristic of haemolytic conditions or where there is ineffective erythropoiesis, however total bilirubin very rarely exceeds 100 μmol/L in such conditions. The Bilirubin EQA programme is designed to assess laboratory and method performance in the laboratory investigation of jaundice for adults and neonates. Four liquid human serum samples are distributed monthly, with a minimum of 48 samples distributed over the year covering the clinically relevant range. The samples consist of a panel of 8 linearly related samples produced from donations from healthy volunteers spiked with conjugated and a mixed isomer source of unconjugated bilirubin. The four samples per distribution allows for the assessment of within laboratory imprecision whilst distribution of the same sample on a number of occasions over the year allows for the assessment of between batch imprecision. This programme is designed to assess laboratory and method performance, including linearity, bias, within and between batch imprecision. Key Features: - Liquid human serum samples. Panel of samples covering the pathological range for the laboratory assessment of jaundice in neonates and adults. - Programme design assesses both laboratory and method performance, including linearity, bias, within and between batch imprecision. - Suitable for Laboratory analysers, Blood Gas analysers and POCT devices. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/eqa/bilirubin/ or contact@weqas.com | |||||||||
| Keywords | ||||||||||
| Product groups |
Health care / medical devices
|
|||||||||
| Testing fields |
Medical analysis
|
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | Suitable for Laboratory analysers, Blood Gas analysers and POCT devices. | |||||||||
| Linked to specific legislation / standards | Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195 | |||||||||
| Additional, subsidiary aims | validation of testing methods | |||||||||
| Number of participants | ||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043 |
|||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||
| Regularly operated | Yes (Frequency: Monthly. Samples: 4 x 1.0mL. ) | |||||||||
| Year of first operation | 1968 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.